|
GSK3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81322999999178E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.456700E-03 |
| Normal-vs-Stage2 |
1.876070E-03 |
| Normal-vs-Stage3 |
5.33679999970005E-07 |
| Normal-vs-Stage4 |
3.87140000002173E-06 |
| Stage1-vs-Stage2 |
8.626100E-02 |
| Stage1-vs-Stage3 |
1.338260E-03 |
| Stage1-vs-Stage4 |
4.118600E-03 |
| Stage2-vs-Stage3 |
5.648200E-01 |
| Stage2-vs-Stage4 |
5.605000E-01 |
| Stage3-vs-Stage4 |
9.571400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42429999999894E-06 |
| Normal-vs-AfricanAmerican |
8.798100E-02 |
| Normal-vs-Asian |
6.773000E-01 |
| Caucasian-vs-AfricanAmerican |
2.254400E-01 |
| Caucasian-vs-Asian |
8.404300E-02 |
| AfricanAmerican-vs-Asian |
3.177800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67800000017549E-07 |
| Normal-vs-Female |
1.064260E-02 |
| Male-vs-Female |
6.641000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.358400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.918700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.1322999999841E-06 |
| Normal-vs-Age(81-100Yrs) |
5.50989998071572E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.395200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.592000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.356700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.482310E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.6413999999515E-07 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.836920E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.838000E-01 |
| Normal-vs-Grade 2 |
7.516400E-03 |
| Normal-vs-Grade 3 |
1.31010000004039E-06 |
| Normal-vs-Grade 4 |
2.87350000016673E-07 |
| Grade 1-vs-Grade 2 |
9.616300E-02 |
| Grade 1-vs-Grade 3 |
2.976200E-03 |
| Grade 1-vs-Grade 4 |
1.974290E-02 |
| Grade 2-vs-Grade 3 |
7.681900E-03 |
| Grade 2-vs-Grade 4 |
1.815210E-03 |
| Grade 3-vs-Grade 4 |
2.882600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.122170E-02 |
| Normal-vs-ccB subtype |
7.442700E-04 |
| ccA subtype-vs-ccB subtype |
3.122600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.447700E-04 |
| Normal-vs-N1 |
2.667200E-01 |
| N0-vs-N1 |
7.606800E-01 |
|
|
